regulatory
confidence high
sentiment negative
materiality 1.00
Accelerate Diagnostics, Inc: Nasdaq/NYSE listing notice — Accelerate Diagnostics to be delisted from Nasdaq after Chapter 11 filing; shares to trade OTC under AXDXQ
Accelerate Diagnostics, Inc
- Filed Chapter 11 bankruptcy on May 8, 2025; Nasdaq cited public interest concerns and bid price deficiencies.
- Common stock suspended at Nasdaq open on May 15, 2025; company will not appeal delisting.
- Expects to trade OTC under symbol AXDXQ starting May 15, 2025; no assurance OTC trading will continue.
- Company warns holders of Securities face significant or complete loss on investment.